Monksland and Roscommon welcomes all that Jazz

Jazz Pharmaceuticals launched a new manufacturing and development facility in Monksland, Co. Roscommon on Tuesday. The new €50 million facility is expected to employ up to 50 people in the area.

  The Minister for Jobs, Enterprise, and Innovation, Mary Mitchell O’Connor, joined Chief Executive of Jazz, Bruce Cozadd, Global Head of Life Sciences of IDA Ireland, Barry Heavey and Minister for Communications, Climate Change and Environment, Denis Naughten to mark the official opening of the facility on the 17-acre site in Monksland.

  This is the first directly owned, managed and operated manufacturing facility built by Jazz and the company has invested approximately €50 million in its development, which commenced in February 2014 and was supported by IDA Ireland. The facility has recently secured full regulatory approval from the United States (U.S.) Food and Drugs Administration (FDA) and the Health Products Regulatory Authority in Ireland.

  The company expects to employ up to 50 people within three years. Jazz is a global pharmaceutical company with its headquarters in Dublin, Ireland where it employees approximately 100 people.

  Speaking at the event, Chief Executive, Bruce Cozadd said: “We were encouraged to come to Roscommon because of the excellent track record of this community in supporting the pharmaceutical industry and the pool of local talent available. We would like to acknowledge the local community, the Roscommon Country Council and IDA Ireland for their continued support and collaboration, and note the remarkable pro-business environment in Ireland that facilitates investments like this one.”

  Minister Mary Mitchell O’Connor said: “Having a global pharmaceutical company of this calibre establish such a facility in Co. Roscommon is hugely significant, demonstrating serious commitment by the company to the region. The jobs created when the facility is operating at full capacity will be of great benefit to the local area and economy.”

  Minister Naughten said: “Today’s opening and significant investment by Jazz Pharmaceuticals is hugely important for Monksland. It is a testament to the talent and expertise of the people of Roscommon. We welcome the new facility and greatly appreciate the investment and loyalty to the region shown by Jazz Pharmaceuticals and to the people of Roscommon.”